Takeda Pharmaceutical Co (SSE:4502) Days Sales Outstanding : 60.42 (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Takeda Pharmaceutical Co Days Sales Outstanding?

Takeda Pharmaceutical Co's average Accounts Receivable for the three months ended in Dec. 2023 was 円735,779 Mil. Takeda Pharmaceutical Co's Revenue for the three months ended in Dec. 2023 was 円1,111,186 Mil. Hence, Takeda Pharmaceutical Co's Days Sales Outstanding for the three months ended in Dec. 2023 was 60.42.

The historical rank and industry rank for Takeda Pharmaceutical Co's Days Sales Outstanding or its related term are showing as below:

SSE:4502' s Days Sales Outstanding Range Over the Past 10 Years
Min: 62.76 Med: 86.32 Max: 92.96
Current: 63.85

During the past 13 years, Takeda Pharmaceutical Co's highest Days Sales Outstanding was 92.96. The lowest was 62.76. And the median was 86.32.

SSE:4502's Days Sales Outstanding is ranked better than
58.14% of 1001 companies
in the Drug Manufacturers industry
Industry Median: 71.68 vs SSE:4502: 63.85

Takeda Pharmaceutical Co's Days Sales Outstanding declined from Dec. 2022 (61.05) to Dec. 2023 (60.42).

Takeda Pharmaceutical Co Days Sales Outstanding Historical Data

The historical data trend for Takeda Pharmaceutical Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takeda Pharmaceutical Co Days Sales Outstanding Chart

Takeda Pharmaceutical Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Days Sales Outstanding

Get a 7-Day Free Trial

92.96

78.39

85.80

76.63

62.76

Takeda Pharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															61.05	65.95	63.25	67.72	60.42

Competitive Comparison of Takeda Pharmaceutical Co's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Takeda Pharmaceutical Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Takeda Pharmaceutical Co's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Takeda Pharmaceutical Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Takeda Pharmaceutical Co's Days Sales Outstanding falls into.

Takeda Pharmaceutical Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Takeda Pharmaceutical Co's Days Sales Outstanding for the fiscal year that ended in Mar. 2023 is calculated as

	Days Sales Outstanding (A: Mar. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2022 )	+	Accounts Receivable (A: Mar. 2023 ))	/	count )	/	Revenue (A: Mar. 2023 )	*	Days in Period
=	( (710304	+	674691)	/	2 )	/	4027478	*	365
=	692497.5					/	4027478	*	365
=	62.76

Takeda Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (755327	+	716230)	/	2 )	/	1111186	*	365 / 4
=	735778.5					/	1111186	*	365 / 4
=	60.42

Takeda Pharmaceutical Co (SSE:4502) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Takeda Pharmaceutical Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Takeda Pharmaceutical Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Takeda Pharmaceutical Co (SSE:4502) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (SSE:4502) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

TAK:USA TKPHF:USA TAK:Mexico 4502:Japan TKD:Germany TAKP34:Brazil

Address

1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668

Website

https://www.takeda.com

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4 trillion in fiscal 2022. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.

Takeda Pharmaceutical Co (SSE:4502) Headlines

No Headlines